Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Huatao Pharmaceutical is a Chinese pharmaceutical company focused on the research, development, and manufacturing of finished dosage forms and active pharmaceutical ingredients (APIs). The company operates production lines for various formulations, including tablets, capsules, and granules, catering primarily to the domestic Chinese market. Its product portfolio covers a range of therapeutic areas such as gastrointestinal health, respiratory conditions, and cardiovascular support. Jiangxi Huatao Pharmaceutical emphasizes compliance with Good Manufacturing Practice (GMP) standards to ensure the quality and safety of its medicinal products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiang Xihua Too Pharmaceutical.